ARCHIVES

OMB Restriction On Reprogramming Threatens Grants Of Three Centers, Possible Restorations

This article is from The Cancer Letter archive.

Vol. 12 No. 23 | June 6, 1986

Download PDF Visit The Full Archive

Related Articles

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

January 27, 2006

Cancer Control: Incidence, Death Rates Continue To Fall, Annual Reports Says

April 23, 1999

Phase III Cyramza Trial Meets OS Primary Endpoint

September 26, 2014

Task Force Recommendations Submitted For Control/Centers New Division

August 3, 1979

Radiation To Stem Cell Niche Improved PFS In Glioblastoma

August 27, 2010

Seattle Cancer Care Alliance Marks its 10th Anniversary—January 2011

June 28, 2021